+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Non-opioid Pain Patches Market Research Report by Patch Type (Capsaicin Patches, Diclofenac Patches, and Ketoprofen Patches), Indication, Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5460257
  • Report
  • April 2022
  • Region: Global
  • 180 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • 3M Company
  • AstraZeneca PLC
  • Baxter International Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck KGaA
The Global Non-opioid Pain Patches Market size was estimated at USD 552.51 million in 2021, USD 622.13 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.77% to reach USD 1,136.75 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Non-opioid Pain Patches to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Patch Type, the market was studied across Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches, Lidocaine Patches, and Methyl Salicylate Patches.
  • Based on Indication, the market was studied across Arthritis, Back Pain, Fibromyalgia, Migraines & Headaches, Muscle Strain & Sprains, and Post-herpetic Neuralgia.
  • Based on Distribution, the market was studied across Drug Stores, Hospitals, and Online Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Non-opioid Pain Patches market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Non-opioid Pain Patches Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Non-opioid Pain Patches Market, including 3M Company, Abbott Laboratories, AstraZeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health, Inc., Eli Lilly and Company, Endo International PLC, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Medtronic PLC, Merck KGaA, Novartis AG, PerkinElmer, Inc., Pfizer Inc., Sorrento Therapeutics, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co., Ltd., Thermo Fisher Scientific Inc., Viatris Inc., and Virpax Pharmaceuticals, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Non-opioid Pain Patches Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Non-opioid Pain Patches Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Non-opioid Pain Patches Market?
4. What is the competitive strategic window for opportunities in the Global Non-opioid Pain Patches Market?
5. What are the technology trends and regulatory frameworks in the Global Non-opioid Pain Patches Market?
6. What is the market share of the leading vendors in the Global Non-opioid Pain Patches Market?
7. What modes and strategic moves are considered suitable for entering the Global Non-opioid Pain Patches Market?
Frequently Asked Questions about the Global Non-opioid Pain Patches Market

What is the estimated value of the Global Non-opioid Pain Patches Market?

The Global Non-opioid Pain Patches Market was estimated to be valued at $552.5 Million in 2021.

What is the growth rate of the Global Non-opioid Pain Patches Market?

The growth rate of the Global Non-opioid Pain Patches Market is 12.7%, with an estimated value of $1136.8 Million by 2027.

What is the forecasted size of the Global Non-opioid Pain Patches Market?

The Global Non-opioid Pain Patches Market is estimated to be worth $1136.8 Million by 2027.

Who are the key companies in the Global Non-opioid Pain Patches Market?

Key companies in the Global Non-opioid Pain Patches Market include 3M Company, Abbott Laboratories, AstraZeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health, Inc., Eli Lilly and Company, Endo International PLC and Johnson & Johnson.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • AstraZeneca PLC
  • Baxter International Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck KGaA

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
5.1.2. Restraints
5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
5.1.3. Opportunities
5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
5.1.3.2. Rising R&D in Pain Management Treatments
5.1.4. Challenges
5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Non-opioid Pain Patches Market, by Patch Type
6.1. Introduction
6.2. Capsaicin Patches
6.3. Diclofenac Patches
6.4. Ketoprofen Patches
6.5. Lidocaine Patches
6.6. Methyl Salicylate Patches
7. Non-opioid Pain Patches Market, by Indication
7.1. Introduction
7.2. Arthritis
7.3. Back Pain
7.4. Fibromyalgia
7.5. Migraines & Headaches
7.6. Muscle Strain & Sprains
7.7. Post-herpetic Neuralgia
8. Non-opioid Pain Patches Market, by Distribution
8.1. Introduction
8.2. Drug Stores
8.3. Hospitals
8.4. Online Pharmacies
9. Americas Non-opioid Pain Patches Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Non-opioid Pain Patches Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Non-opioid Pain Patches Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.2. Abbott Laboratories
13.3. AstraZeneca PLC
13.4. B. Braun Melsungen AG
13.5. Baxter International Inc.
13.6. Cardinal Health, Inc.
13.7. Eli Lilly and Company
13.8. Endo International PLC
13.9. Hisamitsu Pharmaceutical Co., Inc.
13.10. Johnson & Johnson
13.11. Medtronic PLC
13.12. Merck KGaA
13.13. Novartis AG
13.14. PerkinElmer, Inc.
13.15. Pfizer Inc.
13.16. Sorrento Therapeutics, Inc.
13.17. TEH SENG Pharmaceutical Mfg. Co., Ltd.
13.18. Teikoku Seiyaku Co., Ltd.
13.19. Thermo Fisher Scientific Inc.
13.20. Viatris Inc.
13.21. Virpax Pharmaceuticals, Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NON-OPIOID PAIN PATCHES MARKET: DYNAMICS
FIGURE 2. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2027
FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2027
FIGURE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 31. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 33. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. GLOBAL NON-OPIOID PAIN PATCHES MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL NON-OPIOID PAIN PATCHES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NON-OPIOID PAIN PATCHES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL NON-OPIOID PAIN PATCHES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. GLOBAL NON-OPIOID PAIN PATCHES MARKET: SCORES
TABLE 107. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL NON-OPIOID PAIN PATCHES MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL NON-OPIOID PAIN PATCHES MARKET: RANKING
TABLE 110. GLOBAL NON-OPIOID PAIN PATCHES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 111. GLOBAL NON-OPIOID PAIN PATCHES MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL NON-OPIOID PAIN PATCHES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL NON-OPIOID PAIN PATCHES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL NON-OPIOID PAIN PATCHES MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL NON-OPIOID PAIN PATCHES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 116. GLOBAL NON-OPIOID PAIN PATCHES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 3M Company
  • Abbott Laboratories
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cardinal Health, Inc.
  • Eli Lilly and Company
  • Endo International PLC
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • PerkinElmer, Inc.
  • Pfizer Inc.
  • Sorrento Therapeutics, Inc.
  • TEH SENG Pharmaceutical Mfg. Co., Ltd.
  • Teikoku Seiyaku Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Viatris Inc.
  • Virpax Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...